[DOI] [PubMed] [Google Scholar] 103.Mller-Lissner SA, Kamm MA, Scarpignato C
In a placebo-controlled study of 70 -amyloid positive patients with either amnestic mild cognitive impairment (a precursor to AD) or mild AD, those receiving 600 mg/day of benfotiamine for 12 months experienced less cognitive decline compared to placebo, but the differences did not reach statistical significance (p=0.125
Tresiba addresses the symptom (high blood sugar) without addressing the root cause (insulin resistance driven by excess adiposity)
However, with Fitty GLP-1 Daily, you can expect zero side effects when following the correct dosage, as the product is designed to be gentle on the body while providing effective results
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients
Tamouza R, Volt F, Richard J-R, Wu C-L, Bouassida J, Boukouaci W, Lansiaux P, Cappelli B, Scigliuolo GM, Rafii H, Kenzey C, Mezouad E, Naamoune S, Chami L, Lejuste F, Farge D and Gluckman E (2022) Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review